BusinessProfire Energy, Inc. Releases Enhanced Capabilities for the PF 3100 Burner Management SystemBy Nasdaq OMXNov 2, 2017, 9:15 PM UTC
BusinessMyriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive DisorderBy Nasdaq OMXNov 2, 2017, 11:05 AM UTC
BusinessConfirmed Delivery of 5.2 MW U.S. Pipeline Project Fuels Capstone’s Push Towards its Near-Term Adjusted EBITDA Breakeven MilestoneBy Nasdaq OMXOct 31, 2017, 12:30 PM UTC
BusinessEndoPredict (EPclin) Shown in Second Study to be More Effective than Oncotype DX® (RS) in Women with Intermediate Risk of Breast Cancer RecurrenceBy Nasdaq OMXOct 26, 2017, 11:05 AM UTC
BusinessBlueLinx Announces Pricing of Public Secondary Offering by Selling StockholderBy Nasdaq OMXOct 19, 2017, 3:32 AM UTC
BusinessCapstone Turbine Grants Turbine International Exclusive Distribution Rights for the Oil and Gas Market in Russia in Exchange for $6.4 MillionBy Nasdaq OMXOct 18, 2017, 12:30 PM UTC
BusinessMyriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza® (olaparib) in Metastatic Breast CancerBy Nasdaq OMXOct 18, 2017, 11:00 AM UTC
